These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25355880)

  • 1. Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.
    Li YP; Ramirez S; Mikkelsen L; Bukh J
    J Virol; 2015 Jan; 89(1):811-23. PubMed ID: 25355880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system.
    Li YP; Ramirez S; Jensen SB; Purcell RH; Gottwein JM; Bukh J
    Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19757-62. PubMed ID: 23151512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
    Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
    Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors.
    Ramirez S; Li YP; Jensen SB; Pedersen J; Gottwein JM; Bukh J
    Hepatology; 2014 Feb; 59(2):395-407. PubMed ID: 23913364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.
    Scheel TK; Gottwein JM; Carlsen TH; Li YP; Jensen TB; Spengler U; Weis N; Bukh J
    J Virol; 2011 Mar; 85(6):2891-906. PubMed ID: 21177811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of nucleotides in the 5'UTR and amino acids substitutions that are essential for the infectivity of 5'UTR-NS5A recombinant of hepatitis C virus genotype 1b (strain Con1).
    Li J; Feng S; Liu X; Guo M; Chen M; Chen Y; Rong L; Xia J; Zhou Y; Zhong J; Li YP
    Virology; 2018 May; 518():253-263. PubMed ID: 29549787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
    Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
    J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with hepatitis C virus protease and NS5A inhibitors is effective against recombinant genotype 1a, 2a, and 3a viruses.
    Gottwein JM; Jensen SB; Li YP; Ghanem L; Scheel TK; Serre SB; Mikkelsen L; Bukh J
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1291-303. PubMed ID: 23274664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains.
    Li YP; Ramirez S; Gottwein JM; Scheel TK; Mikkelsen L; Purcell RH; Bukh J
    Proc Natl Acad Sci U S A; 2012 May; 109(18):E1101-10. PubMed ID: 22467829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.
    Pham LV; Ramirez S; Carlsen THR; Li YP; Gottwein JM; Bukh J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization.
    Scheel TK; Gottwein JM; Jensen TB; Prentoe JC; Hoegh AM; Alter HJ; Eugen-Olsen J; Bukh J
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):997-1002. PubMed ID: 18195353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
    Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP
    J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an Infectious Cell Culture System for Hepatitis C Virus Genotype 6a Clinical Isolate Using a Novel Strategy and Its Sensitivity to Direct-Acting Antivirals.
    Chen M; Zheng F; Yuan G; Duan X; Rong L; Liu J; Feng S; Wang Z; Wang M; Feng Y; Zhou Q; Li J; Deng K; Li C; Xia J; Rao G; Zhou Y; Fu Y; Li YP
    Front Microbiol; 2018; 9():2950. PubMed ID: 30564209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies.
    Gottwein JM; Scheel TK; Callendret B; Li YP; Eccleston HB; Engle RE; Govindarajan S; Satterfield W; Purcell RH; Walker CM; Bukh J
    J Virol; 2010 May; 84(10):5277-93. PubMed ID: 20200247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies.
    Pedersen J; Carlsen TH; Prentoe J; Ramirez S; Jensen TB; Forns X; Alter H; Foung SK; Law M; Gottwein J; Weis N; Bukh J
    Hepatology; 2013 Nov; 58(5):1587-97. PubMed ID: 23729237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.
    Gottwein JM; Scheel TK; Jensen TB; Lademann JB; Prentoe JC; Knudsen ML; Hoegh AM; Bukh J
    Hepatology; 2009 Feb; 49(2):364-77. PubMed ID: 19148942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.
    Murayama A; Sugiyama N; Suzuki R; Moriyama M; Nakamura N; Mochizuki H; Wakita T; Kato T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.
    Bungyoku Y; Shoji I; Makine T; Adachi T; Hayashida K; Nagano-Fujii M; Ide YH; Deng L; Hotta H
    J Gen Virol; 2009 Jul; 90(Pt 7):1681-1691. PubMed ID: 19282429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.
    Scheel TK; Prentoe J; Carlsen TH; Mikkelsen LS; Gottwein JM; Bukh J
    PLoS Pathog; 2012; 8(5):e1002696. PubMed ID: 22654662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.